In advanced pancreatic cancer, the TGF-β pathway is abnormally activated [74], causing quiescent fibroblasts to transform into CAFs that express α-SMA and inhibit the cytotoxic activity of T cells [75, 76]. This evidence concerns the gene TGFB1 and pancreatic neoplasm.